메뉴 건너뛰기




Volumn 39, Issue 8, 2001, Pages 331-335

Blood pressure reduction and tolerability of amlodipine versus nifedipine retard in Chinese patients with Type 2 diabetes mellitus and hypertension: A randomized 1-year clinical trial

Author keywords

Amlodipine; Chinese; Diabetes mellitus; Hypertension; Nifedipine retard

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; NIFEDIPINE;

EID: 0034905101     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP39331     Document Type: Article
Times cited : (5)

References (15)
  • 4
    • 0030737879 scopus 로고    scopus 로고
    • The calcium antagonist controversy: The emerging importance of drug formulation as a determinant of risk
    • (1997) Am J Cardiol , vol.79 , pp. 9-19
    • Epstein, M.1
  • 5
    • 0027768737 scopus 로고
    • New uses for calcium channel blockers - Therapeutic implications
    • (1993) Drugs , vol.46 , pp. 961-975
    • Fisher, M.1    Grotta, J.2
  • 7
    • 0024842528 scopus 로고
    • Blood pressure, proteinuria and their relationship with circulatory mortality: The WHO multinational study of vascular disease in diabetics
    • WHO Multinational Study Group
    • (1989) Diabetes Metab , vol.15 , pp. 273-277
    • Fuller, J.H.1    Head, J.2
  • 9
    • 0024460849 scopus 로고
    • Calcium channel blockers in acute myocardial infarction and unstable angina: An overview of the result from the randomized trial
    • (1989) Br Med J , vol.299 , pp. 1187-1192
    • Held, P.H.1    Yusuf, S.2    Furberg, C.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.